Diagnostic accuracy of antinuclear antibodies and anti-double stranded DNA antibodies in patients of systemic lupus erythematosus presenting with dermatological features

Authors

  • Attiya Tareen
  • Nighat Naqi
  • Aamir Afzal
  • Uzma Malik

Keywords:

Systemic lupus erythematosus (SLE), dermatological features, serological markers

Abstract

Objective To determine the diagnostic accuracy of antinuclear antibodies (ANA) and anti-double stranded DNA (dsDNA) antibodies in systemic lupus erythematosus patients presenting with dermatological features.  Methods In this cross-sectional study, 82 patients diagnosed as having systemic lupus erythematosus (SLE) per American College of Rheumatology (revised criteria 1997) from October 2012 to October 2013 and fulfilling the study’s inclusion criteria were enrolled. These patients were first assessed by the dermatologist for four dermatological features, namely malar rash, discoid rash, photosensitivity and oral ulcers and were than referred to Department of Pathology for assessment of serological markers i.e. ANA and anti-dsDNA antibodies. The diagnostic accuracies of serological markers were analyzed to determine which one of the two serological markers is associated with any of the four dermatological features under observation in our study. Results Out of 82 SLE patients, 77 (93.9%) patients were females and 5 (6.1 %) were males. Male to female ratio in this study was 1:15. Mean age of patients was 34.91 years and ranged between 8-62 years. Photosensitivity, malar rash, oral ulcers and discoid rash were found in 97.5%, 85.3%, 76.8% and 46.3% patients, respectively. ANA was not found to be statistically significantly associated with any of the dermatological features under observation in our study. However, anti-dsDNA antibodies were strongly associated with photosensitivity 0.024 (p<0.05) and malar rash was 0.003 (p<0.05). Conclusion The study proves that anti-dsDNA antibodies have high diagnostic accuracy for photosensitivity and malar rash in SLE patients and can be used alone with confidence in patients presenting with these two dermatological features, without burdening the lab with a lengthy serological evaluation. 

References

Arbuckle MR, James JA, Dennis GJ et al. Rapid clinical progression to diagnosis among African-American men with systemic lupus erythematosus. Lupus. 2003;12:99-106.

Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of SLE. Arthritis Rheum. 1997;40:1725.

Yell JA, Mbuagbaw J, Burge SM. Cutaneous manifestations of systemic lupus erythematosus. Br J Dermatol. 1996;135:355-62.

Eriksson C, Kokkonen H, Johansson M et al. Autoantibodies predate the onset of Systemic Lupus Erythematosus in northern Sweden. Arthritis Res Ther. 2011;13:R30.

Hussain N. Clinical and laboratory manifestations of systemic lupus erythematosus in Pakistani lupus patients. Pak J Zool. 2013;45:605-13.

Tebbe B. Clinical course and prognosis of cutaneous lupus erythematosus. Clin Dermatol. 2004;22:121-4.

Agrawal SR, Tiewsoh I, Rajput A et al. A cross-sectional hospital based study of clinical and immunological profile of systemic lupus erythematosus patients from central rural India. Indian J Allergy Asthma Immunol. 2013;27:33-7.

Lahita RG. The role of sex hormones in systemic lupus erythematosus. Curr Opin Rheumatol. 1999;11:352-6.

Malaviya AN, Chandrasekaran AN, Kumar A, Shamar PN. Systemic lupus erythematosus in India. Lupus. 1997;6:690-70.

Ahmed TA, Ikram N, Hussain T et al. Clinical and laboratory features of SLE in Pakistani patients. J Pak Med Assoc. 2002;52:5-12.

Arbuckle MR, McClain MT, Rubertson MV et al. Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N Engl J Med. 2003;349:1526-33.

Solomon DH, Kavanaugh AF, Schur PH. Evidence-based guidelines for the use of immunologic tests: Antinuclear antibody testing. Arthritis Rheum. 2002;47:434-45.

Kavanaugh AF, Solomon DH. Guidelines for immunologic laboratory testing in rheumatic diseases: Anti DNA antibody tests. Arthritis Rheum. 2002;47:546-55.

Mutasim FD, Adams BB. A practical guide for serologic evaluation of autoimmune connective tissue disease. J Am Acad Dermatol. 2000;42:159-74.

Tozzoli R, Bizzaro N, Tonutti E et al. Guidelines for laboratory use of autoantibody tests in the diagnosis and monitoring of autoimmune rheumatic diseases. Am J Clin Pathol. 2002;117:316-24.

Emlen W, O’Neill L. Clinical significance of antinuclear antibodies: comparison of detection with immunofluorescence and enzyme-linked immunosorbent assay. Arthritis Rheum.1997;40:1612-8.

Egner W. The use of laboratory tests in the diagnosis of SLE. J Clin Pathol. 2000;53:424-32.

Downloads

Published

2016-12-02

How to Cite

1.
Tareen A, Naqi N, Afzal A, Malik U. Diagnostic accuracy of antinuclear antibodies and anti-double stranded DNA antibodies in patients of systemic lupus erythematosus presenting with dermatological features. J Pak Assoc Dermatol [Internet]. 2016Dec.2 [cited 2025Jan.26];24(2):127-31. Available from: http://www.jpad.com.pk/index.php/jpad/article/view/191

Issue

Section

Original Articles